Lexpos News

The Department of Health and Social Care (DHSC) has today (24/03/2026) confirmed the following list of price concessions for March 2026: Drug Pack size Price concession Adapalene 0.1% cream 45 £18.26 Adapalene 0.1% gel 45 £18.26 Alfuzosin 2.5mg tablets 60 £6.67 Amlodipine 2.5mg tablets 28 £3.88 Aripiprazole 15mg tablets 28 £1.02 Aspirin 75mg dispersible tablets 28 [...]

The post March 2026 Price Concessions 2nd Update appeared first on Community Pharmacy England.

The Royal Pharmaceutical Society (RPS) – supported by Community Pharmacy England, charities and patient groups – is calling on the Government to make headway in introducing community pharmacist flexibilities and addressing reimbursement issues that can delay access to medicines. Medicines Shortages: One Year On assesses progress on supply issues since the launch of the RPS’s [...]

The post Call for swift movement on flexibilities and reimbursement changes to tackle supply issues appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Recall: Hibiwash® 500ml (Regent Medical Limited / Mölnlycke Health Care) Drug alert number: EL(26)A/15 Date issued: 23 March 2026 Mölnlycke Health Care are recalling specific batches of Hibiwash® due to microbial contamination at the manufacturing facility, following routine weekly microbiological monitoring. DMRC reference number: DMRC-38814497 Company name:Regent Medical Limited / Mölnlycke Health [...]

The post MHRA Class 2 Medicines Recall: Hibiwash® 500ml (Regent Medical Limited / Mölnlycke Health Care) appeared first on Community Pharmacy England.

A short survey has opened to hear what pharmacy owners think of Community Pharmacy England’s communications and how they could be improved. As we approach three years on from our rebrand to Community Pharmacy England, we’re taking a fresh look at how we communicate and engage with you. Your insight is vital to helping us [...]

The post CPE Comms: Are you getting what you need from us? appeared first on Community Pharmacy England.

NHS England has authorised and published the patient group direction (PGD) for use in the Spring 2026 COVID-19 vaccination campaign. Download the Spring 2026 COVID-19 vaccination PGD The publication of the PGD, follows the earlier publication of a guide to support vaccination sites who intend to participate in the spring programme. The legislation which enabled the development [...]

The post C-19 vac: Spring programme PGD published appeared first on Community Pharmacy England.